Withdrawal from Lithium: Side Effects and Symptoms
The primary risk of stopping lithium is not a traditional withdrawal syndrome but rather a high risk of psychiatric relapse, particularly within the first 6 months after discontinuation, with over 90% of non-compliant patients experiencing mood episode recurrence. 1
Key Withdrawal Phenomena
1. Psychiatric Relapse (Most Critical)
The most significant "side effect" of lithium discontinuation is disease relapse rather than classic withdrawal symptoms:
- Timing: Highest risk occurs within the first 6 months, particularly the first 3 months after stopping 1
- Magnitude: Over 90% of patients who abruptly stop lithium experience relapse, compared to 37.5% who remain compliant 1
- Rebound effect: The risk of manic recurrence after discontinuation exceeds what would be predicted by the natural course of bipolar disorder alone 2
- Even brief interruptions (just a few days) can trigger relapse 2
2. True Withdrawal Symptoms (Less Common)
While controversial and less well-established than relapse risk, a genuine withdrawal syndrome has been documented 3, 4:
Common symptoms include:
- Irritability and restlessness
- Heightened anxiety
- Emotional lability (increased emotional responsiveness)
- Sleep disturbances
- Somatic symptoms: vertigo, dizziness, or lightheadedness 3
Characteristics:
- Symptoms typically occur within the first week of discontinuation 3
- Generally mild and self-limiting, resolving within weeks 3
- Not dependent on the primary psychiatric disorder 3
- Can be difficult to distinguish from early relapse symptoms 2
Critical Clinical Approach
If Discontinuation is Necessary:
Always taper gradually rather than stopping abruptly 1:
- Abrupt discontinuation significantly increases relapse risk 2
- The FDA label does not specify withdrawal symptoms but emphasizes close monitoring 5
- Gradual tapering should occur over weeks to months when possible 2
Close monitoring requirements 1:
- Watch for early signs of mood episode recurrence
- Monitor within the first 6 months, especially the first 3 months
- Educate patients and families about early warning signs of relapse
- Ensure rapid access to resume treatment if needed
Common Pitfalls to Avoid:
- Abrupt cessation: Never stop lithium suddenly unless medically necessary (e.g., severe toxicity, acute renal failure)
- Inadequate patient education: Patients must understand that stopping lithium carries substantial relapse risk, not just minor withdrawal discomfort
- Confusing withdrawal with relapse: Early psychiatric symptoms after discontinuation may represent either phenomenon
- Underestimating relapse timing: The 6-month high-risk window requires sustained vigilance, not just immediate follow-up
Additional Considerations
Who initiates discontinuation matters 6:
- Adverse effects account for 62% of discontinuation episodes
- Most common adverse effects leading to stopping: diarrhea (13%), tremor (11%), polyuria/polydipsia (9%), creatinine elevation (9%), and weight gain (7%)
- Women are twice as likely as men to consult a physician before stopping 6
The evidence base: While multiple studies document withdrawal symptoms 3, 7, 4, 2, the quality remains limited with no large-scale controlled trials specifically designed to characterize lithium withdrawal syndrome. The relapse risk, however, is robustly documented across multiple high-quality studies 1.
Bottom line: Treat lithium discontinuation primarily as a relapse prevention challenge rather than a withdrawal management issue. The psychiatric consequences of stopping lithium far outweigh the relatively mild and transient withdrawal symptoms that may occur.